Aurobindo Pharma Limited — Updates, 21-07-2026: General Updates
21-07-2026 | 04:35 pm
21-07-2026 | 04:35 pm
Aurobindo's CuraTeQ Biologics secured ANVISA approval for its biosimilars facility. This strengthens the company's global regulatory compliance and capability to supply products to the Brazilian and Latin American markets.
No comments yet. Be the first to comment!
